AZN compared with EW: revenue, margins and what each company keeps, and the suppliers and customers both name

AZNAstrazeneca PLC

Mkt capRevenueRevenue

EWEdwards Lifesciences Corp

Mkt capRevenueRevenue

Compare

AZNAstrazeneca PLC

EWEdwards Lifesciences Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AZN

No earnings history for AZN.

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.0%▼−1.42%×0.16

Q1 FY26±8.8%▲+5.56%×0.64

Feb 11 '26±7.3%▲+2.96%×0.41

Oct 31 '25±6.6%▼−1.23%×0.18

= impliedAZN realized, solidEW realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

AZNAstrazeneca PLC

185.59▼−0.53%

Mkt cap$289.4BRevenue—Revenue—

EWEdwards Lifesciences Corp

95.62▲+2.53%

Regular sessionNov 3 '26

Mkt cap$53.0BRevenue$1.7BQ2 FY26Revenue$6.1BFY25

Compare

Regular sessionNov 3 '26

AZNAstrazeneca PLC

EWEdwards Lifesciences Corp

185.59▼−0.53%

Price

95.62▲+2.53%

$289.4B

Mkt cap

$53.0B

—

Revenue

$1.7BQ2 FY26

—

Revenue

$6.1BFY25

AZN185.59▼−0.53%vsEW95.62▲+2.53%Regular sessionNov 3 '26